CAR-T Administrative Policy Update Effective March 15, 2023

Audience: Participating Oncologists

Excellus BlueCross BlueShield will update the administrative policy entitled “Cellular/Chimeric Antigen Receptor T-cell Therapy (CAR-T)” effective March 15, 2023. You can access the individual policies by clicking here. Note: You must login with your username and password to access our administrative policies.